Variants That Affect Function of Calcium Channel TRPV6 Are Associated With Early-Onset Chronic Pancreatitis.


Journal

Gastroenterology
ISSN: 1528-0012
Titre abrégé: Gastroenterology
Pays: United States
ID NLM: 0374630

Informations de publication

Date de publication:
05 2020
Historique:
received: 15 05 2019
revised: 09 12 2019
accepted: 02 01 2020
pubmed: 14 1 2020
medline: 21 10 2020
entrez: 14 1 2020
Statut: ppublish

Résumé

Changes in pancreatic calcium levels affect secretion and might be involved in development of chronic pancreatitis (CP). We investigated the association of CP with the transient receptor potential cation channel subfamily V member 6 gene (TRPV6), which encodes a Ca We performed whole-exome DNA sequencing from a patient with idiopathic CP and from his parents, who did not have CP. We validated our findings by sequencing DNA from 300 patients with CP (not associated with alcohol consumption) and 1070 persons from the general population in Japan (control individuals). In replication studies, we sequenced DNA from patients with early-onset CP (20 years or younger) not associated with alcohol consumption from France (n = 470) and Germany (n = 410). We expressed TRPV6 variants in HEK293 cells and measured their activity using Ca We identified the variants c.629C>T (p.A210V) and c.970G>A (p.D324N) in TRPV6 in the index patient. Variants that affected function of the TRPV6 product were found in 13 of 300 patients (4.3%) and 1 of 1070 control individuals (0.1%) from Japan (odds ratio [OR], 48.4; 95% confidence interval [CI], 6.3-371.7; P = 2.4 × 10 We found that patients with early-onset CP not associated with alcohol consumption carry variants in TRPV6 that affect the function of its product, perhaps by altering Ca

Sections du résumé

BACKGROUND & AIMS
Changes in pancreatic calcium levels affect secretion and might be involved in development of chronic pancreatitis (CP). We investigated the association of CP with the transient receptor potential cation channel subfamily V member 6 gene (TRPV6), which encodes a Ca
METHODS
We performed whole-exome DNA sequencing from a patient with idiopathic CP and from his parents, who did not have CP. We validated our findings by sequencing DNA from 300 patients with CP (not associated with alcohol consumption) and 1070 persons from the general population in Japan (control individuals). In replication studies, we sequenced DNA from patients with early-onset CP (20 years or younger) not associated with alcohol consumption from France (n = 470) and Germany (n = 410). We expressed TRPV6 variants in HEK293 cells and measured their activity using Ca
RESULTS
We identified the variants c.629C>T (p.A210V) and c.970G>A (p.D324N) in TRPV6 in the index patient. Variants that affected function of the TRPV6 product were found in 13 of 300 patients (4.3%) and 1 of 1070 control individuals (0.1%) from Japan (odds ratio [OR], 48.4; 95% confidence interval [CI], 6.3-371.7; P = 2.4 × 10
CONCLUSIONS
We found that patients with early-onset CP not associated with alcohol consumption carry variants in TRPV6 that affect the function of its product, perhaps by altering Ca

Identifiants

pubmed: 31930989
pii: S0016-5085(20)30017-2
doi: 10.1053/j.gastro.2020.01.005
pii:
doi:

Substances chimiques

Calcium Channels 0
TRPV Cation Channels 0
TRPV6 protein, human 0
Trpv6 protein, mouse 0
Calcium SY7Q814VUP

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1626-1641.e8

Informations de copyright

Copyright © 2020 AGA Institute. Published by Elsevier Inc. All rights reserved.

Auteurs

Atsushi Masamune (A)

Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan. Electronic address: amasamune@med.tohoku.ac.jp.

Hiroshi Kotani (H)

Laboratory of Molecular Biology, Department of Synthetic Chemistry and Biological Chemistry, Graduate School of Engineering, Kyoto University, Kyoto, Japan.

Franziska Lena Sörgel (FL)

Else Kröner-Fresenius-Zentrum für Ernährungsmedizin, Paediatric Nutritional Medicine, Technische Universität München, Freising, Germany.

Jian-Min Chen (JM)

Inserm, Univ Brest, EFS, UMR 1078, GGB, Brest, France.

Shin Hamada (S)

Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan.

Reiko Sakaguchi (R)

Laboratory of Molecular Biology, Department of Synthetic Chemistry and Biological Chemistry, Graduate School of Engineering, Kyoto University, Kyoto, Japan; Institute for Integrated Cell-Material Sciences, Kyoto University, Kyoto, Japan.

Emmanuelle Masson (E)

Inserm, Univ Brest, EFS, UMR 1078, GGB, Brest, France; CHU Brest, Service de Génétique, Brest, France.

Eriko Nakano (E)

Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan.

Yoichi Kakuta (Y)

Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan.

Tetsuya Niihori (T)

Department of Medical Genetics, Tohoku University Graduate School of Medicine, Sendai, Japan.

Ryo Funayama (R)

Division of Cell Proliferation, United Centers for Advanced Research and Translational Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan.

Matsuyuki Shirota (M)

Division of Cell Proliferation, United Centers for Advanced Research and Translational Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan.

Tatsuya Hirano (T)

Laboratory of Molecular Biology, Department of Synthetic Chemistry and Biological Chemistry, Graduate School of Engineering, Kyoto University, Kyoto, Japan.

Tetsuya Kawamoto (T)

Laboratory of Molecular Biology, Department of Synthetic Chemistry and Biological Chemistry, Graduate School of Engineering, Kyoto University, Kyoto, Japan.

Atsuki Hosokoshi (A)

Laboratory of Molecular Biology, Department of Synthetic Chemistry and Biological Chemistry, Graduate School of Engineering, Kyoto University, Kyoto, Japan.

Kiyoshi Kume (K)

Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan.

Lara Unger (L)

Else Kröner-Fresenius-Zentrum für Ernährungsmedizin, Paediatric Nutritional Medicine, Technische Universität München, Freising, Germany.

Maren Ewers (M)

Else Kröner-Fresenius-Zentrum für Ernährungsmedizin, Paediatric Nutritional Medicine, Technische Universität München, Freising, Germany.

Helmut Laumen (H)

Else Kröner-Fresenius-Zentrum für Ernährungsmedizin, Paediatric Nutritional Medicine, Technische Universität München, Freising, Germany.

Peter Bugert (P)

Institute of Transfusion Medicine and Immunology, Medical Faculty Mannheim, Heidelberg University, German Red Cross Blood Service of Baden-Württemberg-Hessen, Mannheim, Germany.

Masayuki X Mori (MX)

Laboratory of Molecular Biology, Department of Synthetic Chemistry and Biological Chemistry, Graduate School of Engineering, Kyoto University, Kyoto, Japan.

Volodymyr Tsvilovskyy (V)

Pharmakologisches Institut, Universität Heidelberg, Heidelberg, Germany; German Center for Cardiovascular Research, partner site Heidelberg, Germany.

Petra Weißgerber (P)

Experimentelle und Klinische Pharmakologie und Toxikologie, Universität des Saarlandes, Homburg, Germany.

Ulrich Kriebs (U)

Pharmakologisches Institut, Universität Heidelberg, Heidelberg, Germany; German Center for Cardiovascular Research, partner site Heidelberg, Germany.

Claudia Fecher-Trost (C)

Experimentelle und Klinische Pharmakologie und Toxikologie, Universität des Saarlandes, Homburg, Germany.

Marc Freichel (M)

Pharmakologisches Institut, Universität Heidelberg, Heidelberg, Germany; German Center for Cardiovascular Research, partner site Heidelberg, Germany.

Kalliope N Diakopoulos (KN)

Mildred Scheel Chair of Tumor Metabolism and Comprehensive Cancer Center Munich at the Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.

Alexandra Berninger (A)

Mildred Scheel Chair of Tumor Metabolism and Comprehensive Cancer Center Munich at the Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.

Marina Lesina (M)

Mildred Scheel Chair of Tumor Metabolism and Comprehensive Cancer Center Munich at the Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.

Kentaro Ishii (K)

Department of Gastroenterology and Hepatology, Tokyo Medical University, Tokyo, Japan.

Takao Itoi (T)

Department of Gastroenterology and Hepatology, Tokyo Medical University, Tokyo, Japan.

Tsukasa Ikeura (T)

Department of Gastroenterology and Hepatology, Kansai Medical University, Hirakata, Japan.

Kazuichi Okazaki (K)

Department of Gastroenterology and Hepatology, Kansai Medical University, Hirakata, Japan.

Tom Kaune (T)

Department of Internal Medicine I, Martin Luther University, Halle (Saale), Germany.

Jonas Rosendahl (J)

Department of Internal Medicine I, Martin Luther University, Halle (Saale), Germany.

Masao Nagasaki (M)

Department of Integrative Genomics, Tohoku Medical Megabank Organization, Tohoku University, Sendai, Japan.

Yasuhito Uezono (Y)

Cancer Pathophysiology Division, National Cancer Center Research Institute, Tokyo, Japan.

Hana Algül (H)

Mildred Scheel Chair of Tumor Metabolism and Comprehensive Cancer Center Munich at the Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.

Keiko Nakayama (K)

Division of Cell Proliferation, United Centers for Advanced Research and Translational Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan.

Yoichi Matsubara (Y)

National Center for Child Health and Development, Tokyo, Japan.

Yoko Aoki (Y)

Department of Medical Genetics, Tohoku University Graduate School of Medicine, Sendai, Japan.

Claude Férec (C)

Inserm, Univ Brest, EFS, UMR 1078, GGB, Brest, France; CHU Brest, Service de Génétique, Brest, France.

Yasuo Mori (Y)

Laboratory of Molecular Biology, Department of Synthetic Chemistry and Biological Chemistry, Graduate School of Engineering, Kyoto University, Kyoto, Japan.

Heiko Witt (H)

Else Kröner-Fresenius-Zentrum für Ernährungsmedizin, Paediatric Nutritional Medicine, Technische Universität München, Freising, Germany.

Tooru Shimosegawa (T)

Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH